在耐火或无法解释的慢性咳患者中,对可代因治疗反应者的表征:前性现实世界队列研究
Ji-Yoon Oh1, Sung-Yoon Kang2, Noeul Kang3
1Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Lung
|February 27, 2024
概括
编解对慢性咳的益处有限,只有大约20%的患者出现显著改善. 这凸显了对耐性咳病例的新型抗咳治疗的需要.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性咳影响了专科诊所的大量患者,通常需要服用抗咳药物.
- 耐药或无法解释的慢性咳是一个临床挑战,需要有效的治疗策略.
研究的目的:
- 评估可代因在耐火或无法解释的慢性咳患者中的实际有效性.
- 确定响应可代因治疗的患者的比例和特征.
主要方法:
- 来自韩国慢性咳登记处的数据分析,这是一个多中心前性队列研究.
- 医生根据改善的时间和程度对可代因反应的评估.
- 使用了莱斯特咳问卷,咳严重程度的视觉模拟尺度,以及咳频率的客观测量.
主要成果:
- 在305名患者中,16.7%被归类为可代因反应者,在一周内迅速改善.
- 部分响应者占18.7%,而20.3%是非响应者.
- 高龄,非生产性咳和缺少胃灼热与更好的代代因反应有关.
结论:
- 对于有限的比例 (大约1%) 来说,可代因提供了快速而显著的改善. 20%) 的慢性咳患者.
- 这项研究强调,由于可代因的部分疗效,新型抗咳药物的需求尚未得到满足.
- 对新型治疗剂的进一步研究是有效的慢性咳管理的必要条件.
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
285
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Drugs Used in Upper Respiratory Disorders: Overview
248
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
248
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


